Legal

Investor Alert: June 4 Deadline Approaching in Checkpoint Therapeutics Securities Class Action

Published June 4, 2024

NEW YORK, June 3, 2024—Investors in Checkpoint Therapeutics, Inc. CKPT, a biopharmaceutical company specializing in the development of immunotherapy treatments for solid tumor cancers, are facing an important deadline. The Rosen Law Firm, recognized globally for advocating for investor rights, is calling on investors who purchased securities during the period from March 10, 2021, to December 15, 2023, to secure legal counsel ahead of the impending June 4 deadline. This initiative is in response to a filed securities class action that aims to hold Checkpoint Therapeutics accountable for alleged violations of federal securities laws.

Background on the Securities Class Action

Checkpoint Therapeutics, which is based in New York, New York, has been at the center of legal moves following claims of potential misleading information to the investing public. The lawsuit pertains to shareholders who bought shares in the stated class period and suffered financial losses attributed to said allegations. The upcoming deadline is critical for these shareholders to join the class-action lawsuit.

Checkpoint Therapeutics' Operational Focus

Checkpoint Therapeutics, Inc. operates within the high-stakes biopharmaceutical industry. With a keen focus on advancing novel therapies for cancer patients, the company's pipeline is dedicated to treatments for various solid tumor indications. Their ongoing commitment to immune-oncology research reflects a broader industry movement towards innovative cancer treatments that harness the body's immune system to fight disease.

Investor Participation in the Class Action

Participants in the lawsuit may potentially recover losses that could have been caused by any misconduct by Checkpoint Therapeutics. Investors are encouraged to touch base with counsel prior to the June 4 deadline to discuss their legal rights, the class action, and notably, eligibility to be a lead plaintiff in the litigation.

checkpoint, ckpt, deadline